This invention provides novel aryl piperazine derivatives represented by Formula (I) having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D
3
, 5HT
1A
and 5-HT
2A
receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders, incl. schizophrenia.
本发明提供了具有医疗用途的新型芳基
哌嗪衍
生物,其
化学式表示为(I),特别是作为
多巴胺和
血清素受体的调节剂,优选D3、5HT1A和5-HT2A受体亚型,特别适用于治疗神经精神疾病,包括精神分裂症。